New smartphone program aims to help lung disease patients at home

NCT ID NCT07301398

Not yet recruiting Knowledge-focused Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will create and test a WeChat mini-program that provides health education to people with interstitial lung disease. The program covers disease knowledge, medication, diet, and rehabilitation, and allows patients to check test results and consult with doctors. Researchers hope this will improve patients' quality of life and reduce the need for hospital visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WeChat mini-program health education
What this could lead to: If successful, this could provide a practical, low-cost way for interstitial lung disease patients to manage their condition at home and reduce hospital visits.
What could go wrong: This is a small, early-stage study (92 participants) focused on building and testing a program, not on proving medical benefit. The mini-program may not work for all patients or may not lead to lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease Noncommunicable Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-NEOPLASTIC AND NON-INFECTIOUS DISEASES

More trials for these conditions

Other studies related to the condition(s) this trial covers.